The notion “hepatitis” means inflammation of the liver or its cells, often caused by some virus and accompanied in its initial phase to by symptoms similar to flu: fever, loss of appetite, muscle/joint aches, etc. According to the virus type hepatitis is divided into several types: hepatitis A, В C, D and E. Hepatitis can disappear on its own, but in some cases it can lead to serious liver dysfunctions and severe complications such as fibrosis, liver failure or cancer, cryoglobulinemia, an a lot more.
The world hepatitis drugs market has experienced stable growth over the recent years, driven by the constant increase of demand from developed countries, introduction of new products and technological advancement in the medical industry. It is set to continue growing at a CARG of above 12% through 2015. Gilead Sciences, Merck & Co., GlaxoSmithKline, Bristol-Myers Squibb and Hoffmann-La Roche are amid the key hepatitis market players.
The collection of the research reports found in this catalogue provides an extensive insight into the hepatitis market at different geographical scales. Relevant information on the market size, share, segmentation as well as major factors influencing the market is presented in the researches. The reports offer detailed assessment of the competitive landscape and profile top companies. In addition, discussions of future market prospects for the are at hand in the research reports.
Publications found:
150
Sort by:
Global HCV Saliva Test Kit Market Growth 2026-2032
US$ 3,660.00
The global HCV Saliva Test Kit market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. An HCV saliva test kit is a too...
March 2026
79 pages
Hepatitis B & C Therapeutics Market - 2024-2033
US$ 2,999.00
The Hepatitis B & C Therapeutics Market was valued at US$ 17.02 billion in 2024 and is anticipated to reach US$ 20.83 billion by 2033, at a CAGR of 0.034 from 2026 to 2032. The report delivers in-dept...
February 2026
213 pages
Hepatitis B Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Acute, Chronic), By Treatment (Immune Modulator Drugs, Antiviral Drugs, Vaccines, Surgery), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Hepatitis B Treatment Market is projected to expand from USD 5.11 Billion in 2025 to USD 6.52 Billion by 2031, registering a CAGR of 4.14%. This market encompasses the distribution of immun...
January 2026
180 pages
Hepatitis D Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Acute, Chronic), By Diagnosis (Blood Tests, Elastography, Liver Biopsy, Serologic Testing, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Hepatitis D Market is projected to expand from USD 2.01 Billion in 2025 to USD 2.73 Billion by 2031, reflecting a compound annual growth rate of 5.24%. This sector involves the creation and...
January 2026
180 pages
Hepatitis C Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Acute Hepatitis C, Chronic Hepatitis C, Others), By Treatment (Antiviral Drugs, Vaccine, Immune Modulator Drugs, Surgery, Others), By Diagnosis ( Liver Biopsy, Blood Tests, Imaging Tests, Others), By Route of Administration (Oral, Parenteral, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Hepatitis C Market is projected to expand from USD 9.32 Billion in 2025 to USD 13.15 Billion by 2031, reflecting a compound annual growth rate of 5.91%. This sector encompasses the manufact...
January 2026
181 pages
Hepatitis B Treatment Market - 2024-2033
US$ 2,999.00
The Hepatitis B Treatment Market was valued at US$ 3.57 billion in 2024 and is anticipated to reach US$ 6.47 billion by 2033, at a CAGR of 0.069 from 2026 to 2032. The report delivers in-depth insight...
June 2025
207 pages
Hepatitis C treatment Market 2026
US$ 2,999.00
The Hepatitis C treatment Market was valued at in and is anticipated to reach by , at a CAGR of 0.135 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regio...
June 2025
217 pages
Alcoholic Hepatitis Treatment Market By Treatment (Corticosteroids, Hemorroheologic Agents, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Providers): Global Opportunity Analysis and Industry Forecast, 2025-2034
US$ 2,655.00
Alcoholic Hepatitis Treatment Market The alcoholic hepatitis treatment market was valued at $668.44 million in 2024 and is estimated to reach $1,064.98 million by 2034, exhibiting a CAGR of 4.7% from...
May 2025
299 pages
North America Hepatitis B Treatment Market - 2024-2033
US$ 2,999.00
The North America Hepatitis B Treatment Market was valued at US$ 1.66 billion in 2024 and is anticipated to reach US$ 3.01 billion by 2033, at a CAGR of 0.069 from 2026 to 2032. The report delivers in...
April 2025
200 pages
Hepatitis C Testing Market By Technique (Immunoassay, PCR, Other Techniques), By Test (Antibody test, Genotype tests, Viral load test), By End User (Hospital and Diagnostic Laboratory, Blood Banks, Other End Users): Global Opportunity Analysis and Industry Forecast, 2024-2035
US$ 2,655.00
The hepatitis C testing market was valued at $1.5billion in 2023 and is estimated to reach $2.6billion by 2035, exhibiting a CAGR of 4.9% from 2024 to 2035. Hepatitis C is a viral infection caused by...
February 2025
312 pages
Egypt Hepatitis C Testing Market, By Test (Antibody Test, Genotype Test, Viral Load Test, Others) By Technique (Immunoassays, Polymerase Chain Reaction (PCR), Others), By End User (Hospitals & Clinics, Diagnostic Laboratories, Others), By Region, Competition Forecast and Opportunities, 2027
US$ 4,000.00
The Egypt Hepatitis C Testing Market is expected to grow at an impressive rate in the forecast period. Hepatitis C is a viral infectious disease affecting the liver, from liver inflammation to liver m...
August 2023
73 pages
France Hepatitis A, B, C, D, E Diagnostics Market, 2019-2023: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review
US$ 3,900.00
... report presents a detailed analysis of the Hepatitis diagnostics market in France. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. ... presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications ...
May 2019
241 pages
Germany Hepatitis A, B, C, D, E Diagnostics Market, 2019-2023: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review
US$ 3,900.00
... report presents a detailed analysis of the Hepatitis diagnostics market in Germany. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. ... presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications ...
May 2019
241 pages
Italy Hepatitis A, B, C, D, E Diagnostics Market, 2019-2023: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review
US$ 3,900.00
... report presents a detailed analysis of the Hepatitis diagnostics market in Italy. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. ... presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of ...
May 2019
241 pages
Japan Hepatitis A, B, C, D, E Diagnostics Market, 2019-2023: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review
US$ 3,900.00
... report presents a detailed analysis of the Hepatitis diagnostics market in Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. ... presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of ...
May 2019
241 pages
Spain Hepatitis A, B, C, D, E Diagnostics Market, 2019-2023: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review
US$ 3,900.00
... report presents a detailed analysis of the Hepatitis diagnostics market in Spain. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. ... presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of ...
May 2019
241 pages
UK Hepatitis A, B, C, D, E Diagnostics Market, 2019-2023: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review
US$ 3,900.00
... ,HBVNAT,HBsAg,HCV,Anti-HBc,Anti-HBs,Anti-HAV,Hepatitis Delta,HBc Ag,HBe Ag, andALT/SGPT In addition to test volume and ... presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA ...
May 2019
241 pages
US Hepatitis A, B, C, D, E Diagnostics Market, 2019-2023: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review
US$ 3,900.00
... ,HBVNAT,HBsAg,HCV,Anti-HBc,Anti-HBs,Anti-HAV,Hepatitis Delta,HBc Ag,HBe Ag, andALT/SGPT In addition to test volume and ... presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA ...
May 2019
241 pages
Global Autoimmune Hepatitis Diagnosis and Treatment Market Forecast, 2018-2023
US$ 3,600.00
... and following segments: 1. Global Autoimmune Hepatitis Diagnosis and Treatment Market by Diagnosis 2. Global Autoimmune Hepatitis Diagnosis and Treatment Market by Treatment 3. Global Autoimmune Hepatitis Diagnosis and Treatment Market by Type 4. Global Autoimmune Hepatitis Diagnosis and Treatment Market ...
January 2019
-
Hepatitis C: Drug Development Pipeline Study, H2 2018
US$ 1,500.00
... cirrhosis or liver cancer. Hepatitis C pipeline comprises of 85 active drugs under active development as of June 2018. Of these, 16 drugs are in Phase 1 and 19 drugs in phase 2. Only 4 drugs progressed to Phase 3. Further ...
June 2018
150 pages
Hepatitis E - Pipeline Review, H1 2018
US$ 2,000.00
... releases. The Hepatitis E (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hepatitis E and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2018
28 pages
Hepatitis Diagnostic Test Market Size, Share & Trends Analysis Report, By Diagnostic Tests (Liver Function, Immunoassays & Nucleic Acid Assays, Imaging, Liver Biopsy), And Segment Forecasts, 2018 - 2025
US$ 5,950.00
... hepatitis diagnostics market is expected to reach USD 6.9 billion by 2025, according to a new report by Grand View Research, Inc. In the past decade, the burden of hepatitis ... rendering a positive impact on the market growth owing to rising demand for diagnostic tests. Furthermore, the adoption of molecular ...
May 2018
90 pages
Hepatitis Treatment Market, 2012 to 2023
US$ 4,400.00
... , Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023 Market Outline: Hepatitis Treatment Market Hepatitis is the disease characterized by the inflammation of the ...
January 2018
202 pages
Global Hepatitis C Virus Testing Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023
US$ 4,400.00
... hepatitis C virus testing market. Globally, hepatitis C virus testing market is segmented based on technique, test type, end-user. Based on technique, hepatitis C virus testing market is segmented as: Polymerase Chain Reaction Tests Immunoassays Others Based on test, hepatitis C virus testing ...
November 2017
221 pages
Global Hepatitis Drug Market & Clinical Trials Insight 2023
US$ 2,400.00
... Hepatitis C drugs. “Global Hepatitis Drug Market & Clinical Trials Insight 2023” report highlights: Prevalence of Hepatitis Infection Available Drug Classes for Hepatitis Drug Global Hepatitis Drug Market Analysis Global Hepatitis (A,B,C,D & E) Drug Clinical Pipeline Insight Marketed Hepatitis Drug Clinical ...
June 2017
550 pages
Hepatitis C [2016]: Bulletin #3
US$ 1,045.00
... presents key opinion leader (KOL) views on recent developments in the hepatitis C virus (HCV) infection market. Topics covered include: Medivir AB communicating ...
June 2017
-
2017 France Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals--Supplier Shares and Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures, Innovative Technologies, Instrumentation Review
US$ 3,510.00
... . The report presents a detailed analysis of the Hepatitis diagnostics market in France. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed ... presents sales and market share estimates for major suppliers of Hepatitis tests.Also, the report examines the market applications of DNA ...
March 2017
241 pages
2017 Germany Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals--Supplier Shares, Competitive Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures, Innovative Technologies, Instrumentation Review
US$ 3,510.00
... . The report presents a detailed analysis of the Hepatitis diagnostics market in Germany. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed ... presents sales and market share estimates for major suppliers of Hepatitis tests.Also, the report examines the market applications of DNA ...
March 2017
241 pages
2017 US Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs--Supplier Shares, Competitive Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures, Innovative Technologies, Instrumentation Review
US$ 3,510.00
... report presents a detailed analysis of the Hepatitis diagnostics market in the US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed ... presents sales and market share estimates for major suppliers of Hepatitis tests.Also, the report examines the market applications of DNA ...
March 2017
241 pages
2017 Italy Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals--Supplier Shares, Competitive Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures, Innovative Technologies, Instrumentation Review
US$ 3,510.00
... . The report presents a detailed analysis of the Hepatitis diagnostics market in Italy. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed ... presents sales and market share estimates for major suppliers of Hepatitis tests.Also, the report examines the market applications of DNA ...
March 2017
241 pages
2017 Japan Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals--Supplier Shares, Competitive Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures, Innovative Technologies, Instrumentation Review
US$ 3,510.00
... . The report presents a detailed analysis of the Hepatitis diagnostics market in Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed ... presents sales and market share estimates for major suppliers of Hepatitis tests.Also, the report examines the market applications of DNA ...
March 2017
241 pages
2017 Spain Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals--Supplier Shares, Competitive Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures, Innovative Technologies, Instrumentation Review
US$ 3,510.00
... . The report presents a detailed analysis of the Hepatitis diagnostics market in Spain. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed ... presents sales and market share estimates for major suppliers of Hepatitis tests.Also, the report examines the market applications of DNA ...
March 2017
241 pages
2017 UK Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals, Public Health Labs--Supplier Shares, Competitive Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures, Innovative Technologies, Instrumentation Review
US$ 3,510.00
... report presents a detailed analysis of the Hepatitis diagnostics market in the UK. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed ... presents sales and market share estimates for major suppliers of Hepatitis tests.Also, the report examines the market applications of DNA ...
March 2017
241 pages
2017 Europe Hepatitis Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
US$ 6,210.00
... report $6,900. DataPack (test volumes, sales forecasts, supplier shares) $4,500.The report presents a detailed analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK). Current scientific views on the Hepatitis definition, epidemiology and etiology are ...
March 2017
295 pages
